Coen Kuijl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Coen Kuijl has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Wilbert Bitter
Amsterdam UMC
6 shared publications - Alexander Speer
Department of Medical Microbiology and Infection Control, Amsterdam UMC, Location VU Medical Center, Amsterdam, The Netherlands
4 shared publications Wilbert Bitter
4 shared publicationsAniek S. Meijers
3 shared publicationsConnie R. Jiménez
3 shared publications- Edith N. G. Houben
Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (10)
Multiple aspartic proteases process PE and PPE proteins on the mycobacterial surface of pathogenic mycobacteria
- 13 August 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (10)
Open AccessMultiple aspartic proteases process PE and PPE proteins on the mycobacterial surface of pathogenic mycobacteria
- Open Access
- 14 January 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (1) , e0211925
A new role for lipoproteins LpqZ and FecB in orchestrating mycobacterial cell envelope biogenesis
Accounting for more deaths than any other bacterial species, Mycobacterium tuberculosis (Mtb) represents a critical threat to public health worldwide. A key factor contributing to Mtb’s virulence is its unique cell envelope, which acts as a protective barrier. Among the components of this envelope, lipoproteins represent a critical but understudied group of proteins. In this study, we focused on 79 conserved putative lipoproteins, shared between Mtb and the closely related M. marinum . Leveraging the CRISPR/Cas9 gene editing system for Mycobacteria, we generated frameshift mutations, targeting one conserved lipoprotein-coding gene at a time. We identified two mutants, lpqZ and fecB , that exhibited increased susceptibility to all tested antibiotics, suggesting critical roles in cell envelope biogenesis. Interestingly, despite having homology to periplasmic substrate-binding proteins (SBPs), neither protein is associated with any inner membrane transporter complex. Instead, co-immunoprecipitation experiments revealed that LpqZ interacts with AftA and FecB interacts with AftB. Both these interaction partners are essential enzymes involved in arabinogalactan and lipoarabinomannan synthesis. Accordingly, we observed alterations for both glycoconjugates in lpqZ and fecB mutants. Together, these findings show that orphaned SBP-like proteins have been repurposed in mycobacteria to aid key enzymes involved in cell envelope biosynthesis. IMPORTANCE: Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), remains the world’s deadliest bacterial infection, in part because the bacterium’s unique cell envelope makes it highly resistant to antibiotics. Understanding how this protective barrier is built is essential for developing better treatments. In this study, we discovered that two previously uncharacterized lipoproteins help maintain the integrity of the mycobacterial cell envelope and contribute to drug resistance. Surprisingly, instead of acting as transport proteins as expected by structural similarity, these molecules regulate enzymes that assemble the bacterial envelope. This discovery highlights a previously unrecognized layer of control in envelope construction and opens new directions for targeting Mtb’s defenses with future therapies.
- 14 January 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (1) , e0211925
Open AccessA new role for lipoproteins LpqZ and FecB in orchestrating mycobacterial cell envelope biogenesis
Accounting for more deaths than any other bacterial species, Mycobacterium tuberculosis (Mtb) represents a critical threat to public health worldwide. A key factor contributing to Mtb’s virulence is its unique cell envelope, which acts as a protective barrier. Among the components of this envelope, lipoproteins represent a critical but understudied group of proteins. In this study, we focused on 79 conserved putative lipoproteins, shared between Mtb and the closely related M. marinum . Leveraging the CRISPR/Cas9 gene editing system for Mycobacteria, we generated frameshift mutations, targeting one conserved lipoprotein-coding gene at a time. We identified two mutants, lpqZ and fecB , that exhibited increased susceptibility to all tested antibiotics, suggesting critical roles in cell envelope biogenesis. Interestingly, despite having homology to periplasmic substrate-binding proteins (SBPs), neither protein is associated with any inner membrane transporter complex. Instead, co-immunoprecipitation experiments revealed that LpqZ interacts with AftA and FecB interacts with AftB. Both these interaction partners are essential enzymes involved in arabinogalactan and lipoarabinomannan synthesis. Accordingly, we observed alterations for both glycoconjugates in lpqZ and fecB mutants. Together, these findings show that orphaned SBP-like proteins have been repurposed in mycobacteria to aid key enzymes involved in cell envelope biosynthesis. IMPORTANCE: Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), remains the world’s deadliest bacterial infection, in part because the bacterium’s unique cell envelope makes it highly resistant to antibiotics. Understanding how this protective barrier is built is essential for developing better treatments. In this study, we discovered that two previously uncharacterized lipoproteins help maintain the integrity of the mycobacterial cell envelope and contribute to drug resistance. Surprisingly, instead of acting as transport proteins as expected by structural similarity, these molecules regulate enzymes that assemble the bacterial envelope. This discovery highlights a previously unrecognized layer of control in envelope construction and opens new directions for targeting Mtb’s defenses with future therapies.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Intracellular Particle Burden Determines Effect on Macrophage Phagocytic Function in Response to Micro‐ and Nanoplastics Exposure
Micro‐ and nanoplastics (MNPs) are increasingly recognized as emerging contaminants, yet their effects on immune health remain poorly understood. As professional phagocytes, macrophages are among the first immune cells to interact with foreign materials and have been shown to internalize MNPs. In this study, we investigated how MNP exposure influences macrophage phagocytic capacity, with emphasis on the intracellular particle burden. Human macrophages were exposed to model polystyrene (PS) particles and environmentally relevant materials, including ultraviolet (UV)‐weathered PS, fragmented polyethylene terephthalate (PET), and cryomilled rubber particles, across a concentration range of 1–100 µg/mL. Particle uptake was confirmed using brightfield images, obtained by image‐enhanced flow cytometry, revealing substantial heterogeneity in MNP internalization across the cell population. At the population level, MNP exposure had limited effects on phagocytosis of bacteria and tumor cells, except for enhanced tumor cell uptake following repeated exposure to high concentrations of UV‐weathered PS. However, stratification by intracellular particle burden showed significantly increased phagocytic activity in highly loaded cells, compared to cells with low or no uptake. Overall, this study demonstrates an increase in phagocytic capacity dependent on internal particle concentration, indicating that alterations in macrophage function may be overlooked when internal particle burden is not considered.
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Open AccessIntracellular Particle Burden Determines Effect on Macrophage Phagocytic Function in Response to Micro‐ and Nanoplastics Exposure
Micro‐ and nanoplastics (MNPs) are increasingly recognized as emerging contaminants, yet their effects on immune health remain poorly understood. As professional phagocytes, macrophages are among the first immune cells to interact with foreign materials and have been shown to internalize MNPs. In this study, we investigated how MNP exposure influences macrophage phagocytic capacity, with emphasis on the intracellular particle burden. Human macrophages were exposed to model polystyrene (PS) particles and environmentally relevant materials, including ultraviolet (UV)‐weathered PS, fragmented polyethylene terephthalate (PET), and cryomilled rubber particles, across a concentration range of 1–100 µg/mL. Particle uptake was confirmed using brightfield images, obtained by image‐enhanced flow cytometry, revealing substantial heterogeneity in MNP internalization across the cell population. At the population level, MNP exposure had limited effects on phagocytosis of bacteria and tumor cells, except for enhanced tumor cell uptake following repeated exposure to high concentrations of UV‐weathered PS. However, stratification by intracellular particle burden showed significantly increased phagocytic activity in highly loaded cells, compared to cells with low or no uptake. Overall, this study demonstrates an increase in phagocytic capacity dependent on internal particle concentration, indicating that alterations in macrophage function may be overlooked when internal particle burden is not considered.
- Open Access
- 17 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11124
Verapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria
The emergence of drug resistance remains a major challenge in the treatment of tuberculosis and other mycobacterial infections. To combat the rise in resistance, strategies that reduce the frequency of resistance mutations are urgently needed. Verapamil is a small-molecule compound that can enhance the potency of companion drugs in combination regimen. Here, we investigate if verapamil can decrease the resistance frequency of antimycobacterial drugs. The results show that verapamil significantly reduces the resistance frequency of multiple antimycobacterial agents, including the DNA gyrase inhibitor moxifloxacin, the protein synthesis inhibitor streptomycin, and the RNA polymerase inhibitor rifampicin in Mycobacterium smegmatis. The presence of point mutations in the target was confirmed for moxifloxacin-resistant M. smegmatis. Suppression of resistance evolution against moxifloxacin by verapamil was also found in the slow-growing, pathogenic mycobacteria M. avium and M. tuberculosis. Real-time qPCR analysis in M. smegmatis showed that verapamil treatment downregulates the expression of multiple efflux pump genes and upregulates DNA repair genes. These findings suggest that verapamil exerts a dual role by interfering with efflux pump functionality and by reducing the probability of chromosomal mutations. The combination of these properties may underlie the promise of verapamil as adjuvant to enhance the effectiveness of current antimycobacterial chemotherapy.
- 17 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11124
Open AccessVerapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria
The emergence of drug resistance remains a major challenge in the treatment of tuberculosis and other mycobacterial infections. To combat the rise in resistance, strategies that reduce the frequency of resistance mutations are urgently needed. Verapamil is a small-molecule compound that can enhance the potency of companion drugs in combination regimen. Here, we investigate if verapamil can decrease the resistance frequency of antimycobacterial drugs. The results show that verapamil significantly reduces the resistance frequency of multiple antimycobacterial agents, including the DNA gyrase inhibitor moxifloxacin, the protein synthesis inhibitor streptomycin, and the RNA polymerase inhibitor rifampicin in Mycobacterium smegmatis. The presence of point mutations in the target was confirmed for moxifloxacin-resistant M. smegmatis. Suppression of resistance evolution against moxifloxacin by verapamil was also found in the slow-growing, pathogenic mycobacteria M. avium and M. tuberculosis. Real-time qPCR analysis in M. smegmatis showed that verapamil treatment downregulates the expression of multiple efflux pump genes and upregulates DNA repair genes. These findings suggest that verapamil exerts a dual role by interfering with efflux pump functionality and by reducing the probability of chromosomal mutations. The combination of these properties may underlie the promise of verapamil as adjuvant to enhance the effectiveness of current antimycobacterial chemotherapy.
- Open Access
- 12 November 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (11) , e0104425
PPE51 modulates membrane integrity in Mycobacterium marinum
PPE proteins, which are exclusive to mycobacteria, are substrates of type VII secretion systems, also unique to this genus. Their function has been an enigma for a long time, but has recently received attention for their association with nutrient uptake across the mycobacterial outer membrane. One of these nutrient transporters is PPE51, involved in glycerol and glucose uptake in Mycobacterium tuberculosis . We investigated the role of PPE51 proteins in nutrient uptake and membrane integrity using the model organism Mycobacterium marinum , whose genome encodes four paralogs. We created single, double, and triple mutants of ppe51 and noted that the presence of the final ppe51 gene was essential. To determine if PPE51’s function is conserved in M. marinum , we investigated its role in glucose and glycerol uptake and found it to be retained across species. Further analysis of its secretion mechanism revealed that PPE51 proteins are ESX-5 substrates, one of the type VII secretion systems, in line with its proposed role in nutrient transport. Notably, and in contrast to its role in glycerol transport, the ppe51 mutants presented substantially altered membrane permeability, as observed by ethidium bromide influx and increased susceptibility to high-molecular-weight antibiotics, such as rifampicin and vancomycin. Scanning electron microscopy showed that the triple mutant has gross alterations in cell morphology. Furthermore, the triple mutant demonstrated attenuation during infection experiments in murine macrophages, likely due to loss of cell-wall integrity. In summary, we analyzed the characteristics of PPE51 in more detail, revealing a new role in membrane integrity and an indirect link with virulence. IMPORTANCE: The impermeable outer membrane of pathogenic mycobacteria presents a major obstacle to nutrient acquisition and antibiotic penetration. PPE51, a substrate of the ESX-5 secretion system, has previously been linked to glucose and glycerol uptake. Our study in Mycobacterium marinum reveals an unexpected additional role for PPE51 in maintaining membrane integrity. Loss of PPE51 not only impairs nutrient uptake but also causes increased membrane permeability, altered antibiotic susceptibility, and reduced virulence. These findings redefine PPE51 as more than a nutrient transporter, highlighting its broader role in cell envelope stability. This dual function has important implications for understanding how mycobacteria balance impermeability with metabolic needs and suggests new strategies to enhance antibiotic efficacy by targeting membrane-associated proteins like PPE51.
- 12 November 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (11) , e0104425
Open AccessPPE51 modulates membrane integrity in Mycobacterium marinum
PPE proteins, which are exclusive to mycobacteria, are substrates of type VII secretion systems, also unique to this genus. Their function has been an enigma for a long time, but has recently received attention for their association with nutrient uptake across the mycobacterial outer membrane. One of these nutrient transporters is PPE51, involved in glycerol and glucose uptake in Mycobacterium tuberculosis . We investigated the role of PPE51 proteins in nutrient uptake and membrane integrity using the model organism Mycobacterium marinum , whose genome encodes four paralogs. We created single, double, and triple mutants of ppe51 and noted that the presence of the final ppe51 gene was essential. To determine if PPE51’s function is conserved in M. marinum , we investigated its role in glucose and glycerol uptake and found it to be retained across species. Further analysis of its secretion mechanism revealed that PPE51 proteins are ESX-5 substrates, one of the type VII secretion systems, in line with its proposed role in nutrient transport. Notably, and in contrast to its role in glycerol transport, the ppe51 mutants presented substantially altered membrane permeability, as observed by ethidium bromide influx and increased susceptibility to high-molecular-weight antibiotics, such as rifampicin and vancomycin. Scanning electron microscopy showed that the triple mutant has gross alterations in cell morphology. Furthermore, the triple mutant demonstrated attenuation during infection experiments in murine macrophages, likely due to loss of cell-wall integrity. In summary, we analyzed the characteristics of PPE51 in more detail, revealing a new role in membrane integrity and an indirect link with virulence. IMPORTANCE: The impermeable outer membrane of pathogenic mycobacteria presents a major obstacle to nutrient acquisition and antibiotic penetration. PPE51, a substrate of the ESX-5 secretion system, has previously been linked to glucose and glycerol uptake. Our study in Mycobacterium marinum reveals an unexpected additional role for PPE51 in maintaining membrane integrity. Loss of PPE51 not only impairs nutrient uptake but also causes increased membrane permeability, altered antibiotic susceptibility, and reduced virulence. These findings redefine PPE51 as more than a nutrient transporter, highlighting its broader role in cell envelope stability. This dual function has important implications for understanding how mycobacteria balance impermeability with metabolic needs and suggests new strategies to enhance antibiotic efficacy by targeting membrane-associated proteins like PPE51.
- Open Access
A new role for lipoproteins LpqZ and FecB in orchestrating mycobacterial cell envelope biogenesis
Accounting for more deaths than any other bacterial species, Mycobacterium tuberculosis (Mtb) represents a critical threat to public health worldwide. A key factor contributing to Mtb’s virulence is its unique cell envelope, which acts as a protective barrier. Among the components of this envelope, lipoproteins represent a critical but understudied group of proteins. In this study, we focused on 79 conserved putative lipoproteins, shared between Mtb and the closely related M. marinum . Leveraging the CRISPR1-Cas9 (Sth1Cas9) gene editing system for Mycobacteria, we generated frameshift mutations, targeting one conserved lipoprotein-coding gene at a time. We identified two mutants, lpqZ and fecB , that exhibited increased susceptibility to all tested antibiotics, suggesting essential roles in cell envelope biogenesis. Interestingly, despite having homology to periplasmic substrate binding proteins (SBPs), neither protein is associated with any inner membrane transporter complex. Instead, co-immunoprecipitation experiments revealed that LpqZ interacts with AftA and FecB interacts with AftB. Both these interaction partners are essential enzymes involved in arabinogalactan and lipoarabinomannan synthesis. Accordingly, we observed alterations for both glycoconjugates in lpqZ and fecB mutants. Together, these findings show that orphaned SBP-like proteins have been neofunctionalized in mycobacteria to aid key enzymes involved in cell envelope biosynthesis.
Open AccessA new role for lipoproteins LpqZ and FecB in orchestrating mycobacterial cell envelope biogenesis
Accounting for more deaths than any other bacterial species, Mycobacterium tuberculosis (Mtb) represents a critical threat to public health worldwide. A key factor contributing to Mtb’s virulence is its unique cell envelope, which acts as a protective barrier. Among the components of this envelope, lipoproteins represent a critical but understudied group of proteins. In this study, we focused on 79 conserved putative lipoproteins, shared between Mtb and the closely related M. marinum . Leveraging the CRISPR1-Cas9 (Sth1Cas9) gene editing system for Mycobacteria, we generated frameshift mutations, targeting one conserved lipoprotein-coding gene at a time. We identified two mutants, lpqZ and fecB , that exhibited increased susceptibility to all tested antibiotics, suggesting essential roles in cell envelope biogenesis. Interestingly, despite having homology to periplasmic substrate binding proteins (SBPs), neither protein is associated with any inner membrane transporter complex. Instead, co-immunoprecipitation experiments revealed that LpqZ interacts with AftA and FecB interacts with AftB. Both these interaction partners are essential enzymes involved in arabinogalactan and lipoarabinomannan synthesis. Accordingly, we observed alterations for both glycoconjugates in lpqZ and fecB mutants. Together, these findings show that orphaned SBP-like proteins have been neofunctionalized in mycobacteria to aid key enzymes involved in cell envelope biosynthesis.
- Open Access
- 20 December 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (6) , e0281922
The ESX-1 Substrate PPE68 Has a Key Function in ESX-1-Mediated Secretion in Mycobacterium marinum
Pathogenic mycobacteria, suchMycobacterium tuberculosisandMycobacterium marinum, use a type VII secretion system (T7SS) subtype, called ESX-1, to mediate intracellular survival via phagosomal rupture and subsequent translocation of themycobacteriumto the host cytosol. Identifying the ESX-1 substrate that is responsible for this process is problematic because of the intricate network of codependent secretion between ESX-1 substrates.
- 20 December 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (6) , e0281922
Open AccessThe ESX-1 Substrate PPE68 Has a Key Function in ESX-1-Mediated Secretion in Mycobacterium marinum
Pathogenic mycobacteria, suchMycobacterium tuberculosisandMycobacterium marinum, use a type VII secretion system (T7SS) subtype, called ESX-1, to mediate intracellular survival via phagosomal rupture and subsequent translocation of themycobacteriumto the host cytosol. Identifying the ESX-1 substrate that is responsible for this process is problematic because of the intricate network of codependent secretion between ESX-1 substrates.
- Open Access
The ESX-1 substrate PPE68 has a key function in the ESX-1 mediated secretion in Mycobacterium marinum
Mycobacteria use specialized type VII secretion systems (T7SSs) to secrete proteins across their diderm cell envelope. One of the T7SS subtypes, named ESX-1, is a major virulence determinant in pathogenic species such as Mycobacterium tuberculosis and the fish pathogen Mycobacterium marinum. ESX-1 secretes a variety of substrates, called Esx, PE, PPE and Esp proteins, at least some of which as folded heterodimers. Investigations into the functions of these substrates is problematic, because of the intricate network of co-dependent secretion between several ESX-1 substrates. Here, we describe that the ESX-1 substrate PPE68 is essential for secretion of the highly immunogenic substrate EsxA and EspE via the ESX-1 system in M. marinum . While secreted PPE68 is processed on the cell surface, the majority of cell-associated PPE68 of M. marinum and M. tuberculosis is present in a cytosolic complex with its PE partner and the EspG 1 chaperone. Interfering with the binding of EspG 1 to PPE68 blocked its export and the secretion of EsxA and EspE. In contrast, esxA is not required for the secretion of PPE68, revealing hierarchy in co-dependent secretion. Remarkably, the final ten residues of PPE68, a negatively charged domain, seem essential for EspE secretion, but not for the secretion of EsxA and PPE68 itself. This indicates that distinctive domains of PPE68 are involved in secretion of the different ESX-1 substrates. Based on these findings, we propose a mechanistic model for the central role of PPE68 in ESX-1 mediated secretion and substrate co-dependence. Importance: Mycobacterium tuberculosis use type VII secretion systems (T7SSs) to secrete proteins across its uniquely hydrophobic diderm cell envelope. A T7SS subtype, called ESX-1, is one of its most important virulence determinants by mediating intracellular survival through phagosomal rupture and subsequent translocation of the mycobacterium to the host cytosol. Identifying the ESX-1 substrate that is responsible for this process is problematic because of the intricate network of co-dependent secretion between ESX-1 substrates. Here, we provide mechanistic insight into the central role of the ESX-1 substrate PPE68 for the secretion of ESX-1 substrates, using the model organism Mycobacterium marinum . Unravelling the mechanism of co-dependent secretion will aid the functional understanding of T7SSs and will allow the analysis of the individual roles of ESX-1 substrates in the virulence caused by this significant human pathogen.
Open AccessThe ESX-1 substrate PPE68 has a key function in the ESX-1 mediated secretion in Mycobacterium marinum
Mycobacteria use specialized type VII secretion systems (T7SSs) to secrete proteins across their diderm cell envelope. One of the T7SS subtypes, named ESX-1, is a major virulence determinant in pathogenic species such as Mycobacterium tuberculosis and the fish pathogen Mycobacterium marinum. ESX-1 secretes a variety of substrates, called Esx, PE, PPE and Esp proteins, at least some of which as folded heterodimers. Investigations into the functions of these substrates is problematic, because of the intricate network of co-dependent secretion between several ESX-1 substrates. Here, we describe that the ESX-1 substrate PPE68 is essential for secretion of the highly immunogenic substrate EsxA and EspE via the ESX-1 system in M. marinum . While secreted PPE68 is processed on the cell surface, the majority of cell-associated PPE68 of M. marinum and M. tuberculosis is present in a cytosolic complex with its PE partner and the EspG 1 chaperone. Interfering with the binding of EspG 1 to PPE68 blocked its export and the secretion of EsxA and EspE. In contrast, esxA is not required for the secretion of PPE68, revealing hierarchy in co-dependent secretion. Remarkably, the final ten residues of PPE68, a negatively charged domain, seem essential for EspE secretion, but not for the secretion of EsxA and PPE68 itself. This indicates that distinctive domains of PPE68 are involved in secretion of the different ESX-1 substrates. Based on these findings, we propose a mechanistic model for the central role of PPE68 in ESX-1 mediated secretion and substrate co-dependence. Importance: Mycobacterium tuberculosis use type VII secretion systems (T7SSs) to secrete proteins across its uniquely hydrophobic diderm cell envelope. A T7SS subtype, called ESX-1, is one of its most important virulence determinants by mediating intracellular survival through phagosomal rupture and subsequent translocation of the mycobacterium to the host cytosol. Identifying the ESX-1 substrate that is responsible for this process is problematic because of the intricate network of co-dependent secretion between ESX-1 substrates. Here, we provide mechanistic insight into the central role of the ESX-1 substrate PPE68 for the secretion of ESX-1 substrates, using the model organism Mycobacterium marinum . Unravelling the mechanism of co-dependent secretion will aid the functional understanding of T7SSs and will allow the analysis of the individual roles of ESX-1 substrates in the virulence caused by this significant human pathogen.
- Open Access
- 27 April 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (2)
Mycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type VII Secretion Systems for Intracellular Secretion
CpnT, a NAD + glycohydrolase, is the only known toxin that is secreted by Mycobacterium tuberculosis . CpnT is composed of two domains; the C-terminal domain is the toxin, whereas the N-terminal domain is required for secretion.
- 27 April 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (2)
Open AccessMycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type VII Secretion Systems for Intracellular Secretion
CpnT, a NAD + glycohydrolase, is the only known toxin that is secreted by Mycobacterium tuberculosis . CpnT is composed of two domains; the C-terminal domain is the toxin, whereas the N-terminal domain is required for secretion.
- Open Access
- 6 March 2019
- Published by Springer Nature in Microbial Cell Factories
- Vol. 18 (1) , 44
Optimization of secretion and surface localization of heterologous OVA protein in mycobacteria by using LipY as a carrier
Mycobacterium bovis Bacille Calmette-Guérin (BCG) is not only used as a vaccine against tuberculosis but also protects against leprosy and is used as part of bladder cancer treatment to induce a protective immune response. However, protection by BCG vaccination is not optimal. To improve vaccine efficacy, recombinant BCG expressing heterologous antigens has been put forward to elicit antigen-specific cellular and humoral responses. Cell surface localized or secreted antigens induce better immune responses than their cytosolic counterparts. Optimizing secretion of heterologous proteins or protein fragments holds therefore unexplored potential for improving the efficacy of recombinant BCG vaccine candidates. Secretion of heterologous antigens requires crossing the mycobacterial inner and outer membrane. Mycobacteria have specialized ESX or type VII secretion systems that enable translocation of proteins across both membranes. Probing this secretion system could therefore be a valid approach to surface localize heterologous antigens. We show that ESX-5 substrate LipY, a lipase, can be used as a carrier for heterologous secretion of an ovalbumin fragment (OVA). LipY contains a PE domain and a lipase domain, separated by a linker region. This linker domain is processed upon secretion. Fusion of the PE and linker domains of LipY to OVA enabled ESX-5-dependent secretion of the fusion construct LipY-OVA in M. marinum, albeit with low efficiency. Subsequent random mutagenesis of LipY-OVA and screening for increased secretion resulted in mutants with improved heterologous secretion. Detailed analysis identified two mutations in OVA that improved secretion, i.e. an L280P mutation and a protein-extending frameshift mutation. Finally, deletion of the linker domain of LipY enhanced secretion of LipY-OVA, although this mutation also reduced surface association. Further analysis in wild type LipY showed that the linker domain is required for surface association. We show that the ESX-5 system can be used for heterologous secretion. Furthermore, minor mutations in the substrate can enhance secretion. Especially the C-terminal region seems to be important for this. The linker domain of LipY is involved in surface association. These findings show that non-biased screening approaches aid in optimization of heterologous secretion, which can contribute to heterologous vaccine development.
- 6 March 2019
- Published by Springer Nature in Microbial Cell Factories
- Vol. 18 (1) , 44
Open AccessOptimization of secretion and surface localization of heterologous OVA protein in mycobacteria by using LipY as a carrier
Mycobacterium bovis Bacille Calmette-Guérin (BCG) is not only used as a vaccine against tuberculosis but also protects against leprosy and is used as part of bladder cancer treatment to induce a protective immune response. However, protection by BCG vaccination is not optimal. To improve vaccine efficacy, recombinant BCG expressing heterologous antigens has been put forward to elicit antigen-specific cellular and humoral responses. Cell surface localized or secreted antigens induce better immune responses than their cytosolic counterparts. Optimizing secretion of heterologous proteins or protein fragments holds therefore unexplored potential for improving the efficacy of recombinant BCG vaccine candidates. Secretion of heterologous antigens requires crossing the mycobacterial inner and outer membrane. Mycobacteria have specialized ESX or type VII secretion systems that enable translocation of proteins across both membranes. Probing this secretion system could therefore be a valid approach to surface localize heterologous antigens. We show that ESX-5 substrate LipY, a lipase, can be used as a carrier for heterologous secretion of an ovalbumin fragment (OVA). LipY contains a PE domain and a lipase domain, separated by a linker region. This linker domain is processed upon secretion. Fusion of the PE and linker domains of LipY to OVA enabled ESX-5-dependent secretion of the fusion construct LipY-OVA in M. marinum, albeit with low efficiency. Subsequent random mutagenesis of LipY-OVA and screening for increased secretion resulted in mutants with improved heterologous secretion. Detailed analysis identified two mutations in OVA that improved secretion, i.e. an L280P mutation and a protein-extending frameshift mutation. Finally, deletion of the linker domain of LipY enhanced secretion of LipY-OVA, although this mutation also reduced surface association. Further analysis in wild type LipY showed that the linker domain is required for surface association. We show that the ESX-5 system can be used for heterologous secretion. Furthermore, minor mutations in the substrate can enhance secretion. Especially the C-terminal region seems to be important for this. The linker domain of LipY is involved in surface association. These findings show that non-biased screening approaches aid in optimization of heterologous secretion, which can contribute to heterologous vaccine development.